BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 35276895)

  • 21. Neurodegeneration and Neuroprotection in Glaucoma.
    Gauthier AC; Liu J
    Yale J Biol Med; 2016 Mar; 89(1):73-9. PubMed ID: 27505018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiology of primary open-angle glaucoma from a neuroinflammatory and neurotoxicity perspective: a review of the literature.
    Evangelho K; Mogilevskaya M; Losada-Barragan M; Vargas-Sanchez JK
    Int Ophthalmol; 2019 Jan; 39(1):259-271. PubMed ID: 29290065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part I].
    Rokicki W; Dorecka M; Romaniuk W
    Klin Oczna; 2007; 109(7-9):349-52. PubMed ID: 18260296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma.
    Chan HC; Chang RC; Koon-Ching Ip A; Chiu K; Yuen WH; Zee SY; So KF
    Exp Neurol; 2007 Jan; 203(1):269-73. PubMed ID: 17045262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinol modulates neuroprotection and intraocular pressure: A potential multi-target therapeutic intervention for glaucoma.
    Somvanshi RK; Zou S; Kadhim S; Padania S; Hsu E; Kumar U
    Biochim Biophys Acta Mol Basis Dis; 2022 Mar; 1868(3):166325. PubMed ID: 34921975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma.
    Madeira MH; Ortin-Martinez A; Nadal-Nícolas F; Ambrósio AF; Vidal-Sanz M; Agudo-Barriuso M; Santiago AR
    Sci Rep; 2016 Jun; 6():27532. PubMed ID: 27270337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glaucoma as a neurodegenerative disease.
    Gupta N; Yücel YH
    Curr Opin Ophthalmol; 2007 Mar; 18(2):110-4. PubMed ID: 17301611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoietin in Glaucoma: From Mechanism to Therapy.
    Lai YF; Lin TY; Chen YH; Lu DW
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Intraocular Pressure-Lowering Effect of Persimmon leaves (
    Ahn HR; Yang JW; Kim JY; Lee CY; Kim TJ; Jung SH
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31652855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recent Research Efforts to Achieve Neuroprotection, Progression and Treatment of Glaucoma].
    Jacobi A; van Zyl T
    Klin Monbl Augenheilkd; 2020 Feb; 237(2):133-139. PubMed ID: 32040976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bio-tactics for neuroprotection of retinal ganglion cells in the treatment of glaucoma.
    Yadav KS; Sharma S; Londhe VY
    Life Sci; 2020 Feb; 243():117303. PubMed ID: 31953158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenchymal stromal cell-mediated neuroprotection and functional preservation of retinal ganglion cells in a rodent model of glaucoma.
    Mead B; Hill LJ; Blanch RJ; Ward K; Logan A; Berry M; Leadbeater W; Scheven BA
    Cytotherapy; 2016 Apr; 18(4):487-96. PubMed ID: 26897559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinal ganglion cell death in glaucoma: Exploring the role of neuroinflammation.
    Russo R; Varano GP; Adornetto A; Nucci C; Corasaniti MT; Bagetta G; Morrone LA
    Eur J Pharmacol; 2016 Sep; 787():134-42. PubMed ID: 27044433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroprotective therapies for glaucoma.
    Song W; Huang P; Zhang C
    Drug Des Devel Ther; 2015; 9():1469-79. PubMed ID: 25792807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of parkin protects retinal ganglion cells in experimental glaucoma.
    Dai Y; Hu X; Sun X
    Cell Death Dis; 2018 Jan; 9(2):88. PubMed ID: 29367744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotection in glaucoma - Is there a future role?
    Baltmr A; Duggan J; Nizari S; Salt TE; Cordeiro MF
    Exp Eye Res; 2010 Nov; 91(5):554-66. PubMed ID: 20800593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leptin as a neuroprotective agent in glaucoma.
    Gupta A
    Med Hypotheses; 2013 Nov; 81(5):797-802. PubMed ID: 24035688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIF-1 expression in retinal ganglion cells and optic nerve axons in glaucoma.
    Reszeć J; Zalewska R; Bernaczyk P; Chyczewski L
    Folia Histochem Cytobiol; 2012 Oct; 50(3):456-9. PubMed ID: 23042279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular changes in glaucomatous trabecular meshwork. Correlations with retinal ganglion cell death and novel strategies for neuroprotection.
    Saccà SC; Vernazza S; Iorio EL; Tirendi S; Bassi AM; Gandolfi S; Izzotti A
    Prog Brain Res; 2020; 256(1):151-188. PubMed ID: 32958211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.